RECRUITING

PRIDE III Prison Interventions and HIV Prevention Collaboration

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The primary objective of this research project is to identify barriers to scale-up of Opioid Agonist Therapy (OAT) in the justice systems (prisons and probation) in Tajikistan, Kyrgyzstan, Moldova, and Georgia, and establish a NIATx learning collaborative to scale-up OAT, and analyze scale-up utilizing latent class growth analyses in people who inject drugs (PWID).

Official Title

PRIDE III Prison Interventions and HIV Prevention Collaboration

Quick Facts

Study Start:2024-11-05
Study Completion:2028-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06962033

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Quantitative surveys for prison OAT providers
  2. * Being 18 years or older
  3. * Being currently assigned and working as a probation OAT provider for a probation site
  4. 2. ECHO procedures
  5. 1. Quantitative surveys for people in probation
  6. * Being 18 years or older
  7. * Screen yes to opioid injection on the online screener questionnaire
  8. * Currently in probation
  9. 2. Quantitative surveys for probation and prison officers
  10. * Being 18 years or older
  11. * Being currently assigned and working as a probation or prison officer at a probation site
  12. 3. Focus Groups (People in probation)
  13. * Being 18 years or older
  14. * Screen yes to opioid injection criteria on the online screener
  15. * Currently in probation
  16. 4. Focus Groups (Probation and prison officers)
  17. * Being 18 years or older
  18. * Being currently assigned and working as a probation or prison officer at a probation
  19. * Has more than 3 months of field experience
  20. * Works at a probation site within 25 kilometers of an OAT site
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

David Oliveros, MPH
CONTACT
202-805-8118
david.oliveros@yale.edu
Jin Hee Kim, MPH
CONTACT
jinhee.kim@yale.edu

Principal Investigator

Frederick L Altice, MD
PRINCIPAL_INVESTIGATOR
Yale University

Study Locations (Sites)

Yale University
New Haven, Connecticut, 06520
United States

Collaborators and Investigators

Sponsor: Yale University

  • Frederick L Altice, MD, PRINCIPAL_INVESTIGATOR, Yale University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-11-05
Study Completion Date2028-12

Study Record Updates

Study Start Date2024-11-05
Study Completion Date2028-12

Terms related to this study

Additional Relevant MeSH Terms

  • Hiv
  • Opioid Use